Arleen Cromwell, PH. D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 255 S Main St, Richfield, UT 84701 Phone: 435-896-8236 Fax: 435-896-9584 |
Tabitha Campbell, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1000 N Main St Ste A, Richfield, UT 84701 Phone: 435-893-0580 |
News Archive
International effort led by St. Jude Children's Research Hospital scientists is expected to fuel development of targeted therapies and aid the search for unique combinations of cells and mutations that lead to other cancers.
According to a new study, 4 in 10 health care professionals are turning up for work even when they are down with a contagious infection such as a flu. The study titled, "Working with influenza-like illness: Presenteeism among US health care personnel during the 2014-2015 influenza season", was published in the November issue of the American Journal of Infection Control (AJIC).
Eisai Europe Ltd. today announced that it has submitted a marketing authorization application to the European Medicines Agency (EMA) for approval of eribulin mesylate, also known as 'E7389', for the treatment of locally advanced or metastatic breast cancer in Europe. Eribulin mesylate, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Regulatory applications for eribulin mesylate have also been submitted in the United States and Japan.
At Pittcon 2014 Bruker announced a new sample automation system for the minispec mq and mq-one series, a new easy to use and cost-effective system that brings sample automation to routine Time-Domain (TD)-NMR applications. Its fast sample exchange of 10mm OD sample tubes delivers new levels of maximum throughput and thanks to automated and precise tempering times measurement reliability is improved, significantly boosting productivity of the minispec series.
› Verified 4 days ago